Health Education and Health Promotion

Prevalence of Diabetes Mellitus in Adult Residents of Rural Regions of Grash Town, Fars, Iran during 2015-201

Document Type : Original Research

Authors

H. Soori 1
M.N. Mohammadi 2
J. Yoosefi Lebni 3

1 Safety Promotion and Injury Prevention Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Public Health Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Public Health Faculty, Iran University of Medical Sciences, Tehran, Iran

https://doi.org/10.29252/HEHP.7.2.89
Abstract
Aims: To find prevalence and related factors of diabetes mellitus in rural regions of Grash Town located in central Iran (Fars province) composed of 25 rural regions.

Instruments & Methods: This cross sectional study was conducted on a sample of 1523 adults aged ≥30 years, living in rural regions of Grash Town during 2015-2016. We used stratified random sampling. Participants were invited by calls and informed consent was obtained from all. We checked HbA1c of participants and demographic information, past medical history, and some risk factors (BMI, familial and personal history of diabetes and level of physical activity) among them were investigated. Cases with HbA1C≥6.5% were considered diabetics. Pregnant women and people with haemoglobinopathies, anemias, and chronic liver/renal diseases were excluded. Data were analyzed, using SPSS19 software. Statistical significant level was <0.05 in this study.

Findings: In this study, 507(33.3%) cases were with HbA1c≥6.5%, of whom 241 (15.8%) were previously diagnosed as diabetic. Diabetes was associated with age (p<0.001), occupation (p=0.04), education (p<0.001), marital status (p<0.001), BMI (p<0.001), and familial history (p<0.001). Age ≥ 50 years, familial history of diabetes, obesity/overweight, unemployment, low educational attainment, and loss of partner were all more frequent in diabetics.

Conclusion: Prevalence of diabetes measured by HbA1c in this study was greater than most previous studies in Iran. However, most studies have used FBS and we need further studies to determine optimal threshold of HbA1c for diagnosis of diabetes in Iranian population. High risk people should be focused in preventive and control programs.

Keywords

Diabetes mellitus
Glycated Hemoglobin A
Prevalence
Screening
Risk factor
Subjects
  1. 1- Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8: 29.
    2- Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2· 7 million participants. The Lancet. 2011;378(9785):31-40.
    3- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes care. 1998;21(9):1414-31.
    4- Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017; 7: 13461.
    5- Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of diabetes population size and associated economic burden through 2030 in Iran: evidence from micro-simulation Markov model and Bayesian meta-analysis. PloS one. 2015;10(7):e0132505.
    6- Davari M, Boroumand Z, Amini M, Aslani A, Hosseini M. The direct medical costs of outpatient cares of Type 2 diabetes in Iran: A retrospective study. Int J Prev Med. 2016; 7: 72.
    7- American Diabetes Association. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S51-4.
    8- Nasli-Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi-Ghassemabadi R, Khajavi A, Peimani M, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord. 2017; 16: 9.
    9- Larejani B, Zahedi F. Epidemiology of diabetes mellitus in Iran. Iranian Journal of Diabetes and Lipid Disorders. 2001;1(1):1-8. (Persian)
    10- Borissova A-M, Shinkov A, Vlahov J, Dakovska L, Todorov T. Higher Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance Among the Rural Population in Bulgaria. Journal of Endocrinology and Metabolism. 2016;6(2):52-8.
    11- Florkowski C. HbA1c as a Diagnostic Test for Diabetes Mellitus - Reviewing the Evidence. Clin Biochem Rev. 2013; 34(2): 75-83.
    12- American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 (Suppl 1):S62-9.
    13- American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes care. 2018;41(Supplement 1):S13-S27.
    14- Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K, et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes care. 2011;34(1):145-50.
    15- Peter A, Fritsche A, Stefan N, Heni M, Häring H-U, Schleicher E. Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes. 2011;119(4):234-7.
    16- Jeon JY, Ko S-H, Kwon H-S, Kim NH, Kim JH, Kim CS, et al. Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J. 2013; 37(5): 349-357.
    17- Mannarino M, Tonelli M, Allan GM. Tools for practice: screening and diagnosis of type 2 diabetes with HbA1c. Can Fam Physician. 2013 Jan;59(1):42.
    18- Singh SP, Sikri G, Garg MK. Body Mass Index and Obesity : Tailoring "cut-off" for an Asian Indian Male Population. Med J Armed Forces India. 2008; 64(4): 350-3.
    19- Unnikrishnan R, Mohan V. Why screening for type 2 diabetes is necessary even in poor resource settings. J Diabetes Complications. 2015;29(7):961-4.
    20- Backholer K, Chen L, Shaw J. Screening for diabetes. Pathology. 2012;44(2):110-4.
    21- Lim W-Y, Ma S, Heng D, Tai ES, Khoo CM, Loh TP. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore. Sci Rep. 2018;8(1):12419.
    22- Siu AL; U S Preventive Services Task Force. creening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163(11):861-8.
    23- Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50.
    24- Hadaegh F, Bozorgmanesh M, Harati H, Saadat N, Azizi F. High prevalence of diabetes and abnormal glucose tolerance in urban Iranians aged over 20 years: determining an effective screening strategy for un-diagnosed diabetes. Iranian Journal of Endocrinology and Metabolism. 2008;9(4):383-91.
    25- Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC public health. 2009;9(1):167.
    26- Alkandari A, Longenecker JC, Barengo NC, Alkhatib A, Weiderpass E, Al-Wotayan R, et al. The prevalence of pre-diabetes and diabetes in the Kuwaiti adult population in 2014. Diabetes Res Clin Pract. 2018;144:213-23.
    27- Assaad Khalil SH, Megallaa MH, Rohoma KH, Ismael H, AbouSeif M, Kharboush I, et al. Prevalence of type 2 diabetes mellitus in a sample of the adult population of Alexandria, Egypt. Diabetes Res Clin Pract. 2018;144:63-73.
    28- Chow CK, Raju PK, Raju R, Reddy KS, Cardona M, Celermajer DS, et al. The prevalence and management of diabetes in rural India. Diabetes care. 2006;29(7):1717-8
    29- Bagheri P. The comparison of prevalence of diabete and hypertension between rural areas of fars and rural area of emro region. Iranian Journal of Endocrinology and Metabolism. 2011;13(2):157-64.
    30- Razi F, Khashayar P, Ghodssi-Ghassemabadi R, Mehrabzadeh M, Peimani M, Bandarian F, et al. Optimal HbA1c Cut-Off Point for Diagnosis of Type 2 Diabetes in Iranian Adults. 2018;42(6):582-7.
    31- Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes care. 2012;35(12):2650-64.
    32- Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012Prevalence of and Trends in Diabetes Among US AdultsPrevalence of and Trends in Diabetes Among US Adults. JAMA. 2015;314(10):1021-9.
    33- Nguyen QM, Xu J-H, Chen W, Srinivasan SR, Berenson GS. Correlates of Age Onset of Type 2 Diabetes Among Relatively Young Black and White Adults in a Community, The Bogalusa Heart Study. Diabetes care. 2012;35(6):1341-6.
    34- Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh M, Safarian M, Esmaeili H, Parizadeh S, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49(7):571-6.
    35- Babikr WG, Alshahrani ASA, Hamid HGM, Abdelraheem AHMK, Shalayel MHF. The correlation of HbA1c with body mass index and HDL-cholesterol in type 2 diabetic patients. Biomedical Research. 2016;27(4):1280-3.
    36- Bala M, Meenakshi, K M, Gupta A. Correlation of HbA(1C) Levels With Body Mass Index in Newly Diagnosed Polycystic Ovary Syndrome. EJIFCC. 2017;28(3):196-204.
    37- Papazafiropoulou A, Sotiropoulos A, Skliros E, Kardara M, Kokolaki A, Apostolou O, et al. Familial history of diabetes and clinical characteristics in Greek subjects with type 2 diabetes. BMC Endocr Disord. 2009; 9: 12.
    38- Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ. Family history of type 2 diabetes: A population-based screening tool for prevention? Genet Med. 2006;8(2):102-8.
  2. Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29. [Link] [DOI:10.1186/1478-7954-8-29]
  3. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2•7 million participants. Lancet. 2011;378(9785):31-40. [Link] [DOI:10.1016/S0140-6736(11)60679-X]
  4. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31. [Link] [DOI:10.2337/diacare.21.9.1414]
  5. Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: Prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461. [Link] [DOI:10.1038/s41598-017-13379-z]
  6. Javanbakht M, Mashayekhi A, Baradaran HR, Haghdoost A, Afshin A. Projection of diabetes population size and associated economic burden through 2030 in Iran: Evidence from micro-simulation Markov model and Bayesian meta-analysis. PLoS One. 2015;10(7):e0132505. [Link] [DOI:10.1371/journal.pone.0132505]
  7. Davari M, Boroumand Z, Amini M, Aslani A, Hosseini M. The direct medical costs of outpatient cares of type 2 diabetes in Iran: A retrospective study. Int J Prev Med. 2016;7:72. [Link] [DOI:10.4103/2008-7802.181758]
  8. American Diabetes Association. Prevention or delay of type 2 diabetes: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S51-4. [Link] [DOI:10.2337/dc18-S005]
  9. Nasli Esfahani E, Farzadfar F, Kouhnavard M, Ghodssi Ghassemabadi R, Khajavi AR, Peimani M, et al. Iran Diabetes Research Roadmap (IDRR) study: A preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord. 2017;16:9. [Link] [DOI:10.1186/s40200-017-0291-9]
  10. Larejani B, Zahedi F. Epidemiology of diabetes mellitus in Iran. Iran J Diabetes Metab. 2001;1(1):1-8. [Persian] [Link]
  11. Borissova AM, Shinkov A, Vlahov J, Dakovska L, Todorov T. Higher prevalence of diabetes mellitus and impaired glucose tolerance among the rural population in Bulgaria. J Endocrinol Metab. 2016;6(2):52-8. [Link] [DOI:10.14740/jem334w]
  12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62-9. [Link] [DOI:10.2337/dc10-S062]
  13. American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13-27. [Link] [DOI:10.2337/dc18-S002]
  14. Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K, et al. Glycemic thresholds for diabetes-specific retinopathy: Implications for diagnostic criteria for diabetes. Diabetes Care. 2011;34(1):145-50. [Link] [DOI:10.2337/dc10-1206]
  15. Peter A, Fritsche A, Stefan N, Heni M, Häring HU, Schleicher E. Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes. 2011;119(4):234-7. [Link] [DOI:10.1055/s-0030-1270440]
  16. Jeon JY, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, et al. Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J. 2013;37(5):349-57. [Link] [DOI:10.4093/dmj.2013.37.5.349]
  17. Mannarino M, Tonelli M, Allan GM. Tools for practice: Screening and diagnosis of type 2 diabetes with HbA1c. Can Fam Physician. 2013;59(1):42. [Link]
  18. Florkowski C. HbA1c as a diagnostic test for diabetes mellitus - reviewing the evidence. Clin Biochem Rev. 2013;34(2):75-83. [Link]
  19. Singh SP, Sikri G, Garg MK. Body mass index and obesity: Tailoring "cut-off" for an Asian Indian male population. Med J Armed Forces India. 2008;64(4):350-3. [Link] [DOI:10.1016/S0377-1237(08)80019-6]
  20. Unnikrishnan R, Mohan V. Why screening for type 2 diabetes is necessary even in poor resource settings. J Diabetes Complicat. 2015;29(7):961-4. [Link] [DOI:10.1016/j.jdiacomp.2015.05.011]
  21. Backholer K, Chen L, Shaw J. Screening for diabetes. Pathology. 2012;44(2):110-4. [Link] [DOI:10.1097/PAT.0b013e32834e8e12]
  22. Lim WY, Ma S, Heng D, Shyong Tai E, Khoo CM, Loh TP. Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore. Sci Rep. 2018;8:12419. [Link] [DOI:10.1038/s41598-018-29998-z]
  23. Siu AL, U S Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(11):861-8. [Link] [DOI:10.7326/M15-2345]
  24. Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. [Link] [DOI:10.1016/j.diabres.2017.03.024]
  25. Hadaegh F, Bozorgmanesh MR, Harati H, Saadat N, Azizi F. High prevalence of diabetes and abnormal glucose tolerance in urban Iranians aged over 20 years: Determining an effective screening strategy for un-diagnosed diabetes. Iran J Endocrinol Metab. 2008;9(4):383-91. [Persian] [Link]
  26. Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: Methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9:167. [Link] [DOI:10.1186/1471-2458-9-167]
  27. Alkandari A, Longenecker JC, Barengo NC, Alkhatib A, Weiderpass E, Al-Wotayan R, et al. The prevalence of pre-diabetes and diabetes in the Kuwaiti adult population in 2014. Diabetes Res Clin Pract. 2018;144:213-23. [Link] [DOI:10.1016/j.diabres.2018.08.016]
  28. Assaad Khalil SH, Megallaa MH, Rohoma KH, Ismael H, Abou Seif M, Kharboush I, et al. Prevalence of type 2 diabetes mellitus in a sample of the adult population of Alexandria, Egypt. Diabetes Res Clin Pract. 2018;144:63-73. [Link] [DOI:10.1016/j.diabres.2018.07.025]
  29. Chow CK, Raju PK, Raju R, Reddy KS, Cardona M, Celermajer DS, et al. The prevalence and management of diabetes in rural India. Diabetes Care. 2006;29(7):1717-8 [Link] [DOI:10.2337/dc06-0621]
  30. Faramarzi H, Bagheri P, Bahrampour A, Halimi L, Rahimi N, Ebrahimi M. The comparison of prevalence of diabete and hypertension between rural areas of Fars and rural area of EMRO region. Iran J Endocrinol Metab. 2011;13(2):157-64. [Persian] [Link]
  31. Razi F, Khashayar P, Ghodssi Ghassemabadi R, Mehrabzadeh M, Peimani M, Bandarian F, et al. Optimal Glycated hemoglobin cutoff point for diagnosis of type 2 diabetes in Iranian adults. Can J Diabetes. 2018;42(6):582-7. [Link] [DOI:10.1016/j.jcjd.2018.03.005]
  32. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650-64. [Link] [DOI:10.2337/dc12-1801]
  33. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021-9. [Link] [DOI:10.1001/jama.2015.10029]
  34. Nguyen QM, Xu JH, Chen W, Srinivasan SR, Berenson GS. Correlates of age onset of type 2 diabetes among relatively young black and white adults in a community. Diabetes Care. 2012;35(6):1341-6. [] [DOI:10.2337/dc11-1818]
  35. Azimi Nezhad M, Ghayour Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49(7):571-6. [Link]
  36. Walid Gaafar Babikr, Abdulaziz Saad Alturki Alshahrani, Hassan Gumaa Mustafa Hamid, Ahmed Hassan Mohammed Khear Abdelraheem, Mohammed Helmy Faris Shalayel. The correlation of HbA1c with body mass index and HDL-cholesterol in type 2 diabetic patients. Biomed Res. 2016;27(4):1280-3. [Link]
  37. Bala M, Meenakshi, K M, Gupta A. Correlation of HbA1C levels with body mass index in newly diagnosed polycystic ovary syndrome. EJIFCC. 2017;28(3):196-204. [Link]
  38. Papazafiropoulou A, Sotiropoulos A, Skliros E, Kardara M, Kokolaki A, Apostolou O, et al. Familial history of diabetes and clinical characteristics in Greek subjects with type 2 diabetes. BMC Endocr Disord. 2009;9:12. [Link] [DOI:10.1186/1472-6823-9-12]
  39. Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ. Family history of type 2 diabetes: A population-based screening tool for prevention?. Genet Med. 2006;8(2):102-8. [Link] [DOI:10.1097/01.gim.0000200949.52795.df]
Health Education and Health Promotion
Volume 7, Issue 2
Spring 2019
Pages 89-93